Green Pharmacy | Natural Products Sourcebook

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants - Morningstar

Submitted by Anonymous (not verified) on Mon, 03/30/2026 - 11:30

Neurolief Secures Additional $6 Mill

Read more about Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants - Morningstar
Log in to post comments

Pages